Company / Shares Outstanding
Denali Therapeutics Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
144.2M
FY2025
5-year range
120.5M / 144.2M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#66 of 212
Health Care
What the data says
At 144220986.00, Denali Therapeutics Inc.'s shares outstanding ranks #147 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 6424720.00 in FY2016 to 144220986.00 in FY2025.
Based on SEC 10-K filings.
144220986.00 in FY2025 with a 5-year CAGR of +8.4%.
Increased from 135965918.00 to 144220986.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#147 of 212 in Health CareTop 69% of 212This company 144.2M Sector average 306.0M
▼
-52.9% below sector average
Key checks
Key Insights
- Denali Therapeutics Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 4.2% year-over-year.
- Ranks #66 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.73 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 144.2M | +4.2% |
| FY2024 | 138.4M | +1.8% |
| FY2023 | 136.0M | +11.2% |
| FY2022 | 122.3M | +1.5% |
| FY2021 | 120.5M | +25.3% |
| FY2020 | 96.2M | +1.6% |
| FY2019 | 94.7M | +8.2% |
| FY2018 | 87.5M | +484.6% |
| FY2017 | 15.0M | +132.9% |
| FY2016 | 6.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026